161 related articles for article (PubMed ID: 30358016)
1. Going beyond serology for stratifying the risk of CMV infection in transplant recipients.
Navarro D; Fernández-Ruiz M; Aguado JM; Sandonís V; Pérez-Romero P
Rev Med Virol; 2019 Jan; 29(1):e2017. PubMed ID: 30358016
[TBL] [Abstract][Full Text] [Related]
2. Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study.
Molina-Ortega A; Martín-Gandul C; Mena-Romo JD; Rodríguez-Hernández MJ; Suñer M; Bernal C; Sánchez M; Sánchez-Céspedes J; Pérez Romero P; Cordero E
Clin Microbiol Infect; 2019 Jun; 25(6):753-758. PubMed ID: 30292792
[TBL] [Abstract][Full Text] [Related]
3. Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation.
Blanco-Lobo P; Cordero E; Martín-Gandul C; Gentil MA; Suárez-Artacho G; Sobrino M; Aznar J; Pérez-Romero P
J Infect; 2016 May; 72(5):597-607. PubMed ID: 26920791
[TBL] [Abstract][Full Text] [Related]
4. CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor.
Schachtner T; Stein M; Reinke P
Transplantation; 2017 Oct; 101(10):e315-e325. PubMed ID: 28594749
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
[TBL] [Abstract][Full Text] [Related]
7. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
8. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
Mabilangan C; Preiksaitis J; Cervera C;
Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
[TBL] [Abstract][Full Text] [Related]
10. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
Preiksaitis JK; Sandhu J; Strautman M
Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
[TBL] [Abstract][Full Text] [Related]
12. A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients.
Suresh S; Lee BE; Robinson JL; Akinwumi MS; Preiksaitis JK
Pediatr Transplant; 2016 Nov; 20(7):970-980. PubMed ID: 27565955
[TBL] [Abstract][Full Text] [Related]
13. CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.
Mena-Romo JD; Pérez Romero P; Martín-Gandul C; Gentil MÁ; Suárez-Artacho G; Lage E; Sánchez M; Cordero E
J Infect; 2017 Oct; 75(4):336-345. PubMed ID: 28599954
[TBL] [Abstract][Full Text] [Related]
14. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
Melendez D; Razonable RR
Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
[TBL] [Abstract][Full Text] [Related]
15. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
Rittà M; Costa C; Sidoti F; Ballocco C; Ranghino A; Messina M; Biancone L; Cavallo R
New Microbiol; 2015 Jul; 38(3):329-35. PubMed ID: 26147141
[TBL] [Abstract][Full Text] [Related]
16. Donor Cytomegalovirus Transmission Patterns in Solid Organ Transplant Recipients With Primary Infection.
Hasing ME; Pang XL; Mabilangan C; Preiksaitis JK
J Infect Dis; 2021 Mar; 223(5):827-837. PubMed ID: 32706857
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients.
Rowshani AT; Bemelman FJ; van Leeuwen EM; van Lier RA; ten Berge IJ
Transplantation; 2005 Feb; 79(4):381-6. PubMed ID: 15729162
[TBL] [Abstract][Full Text] [Related]
19. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
Schlott F; Steubl D; Hoffmann D; Matevossian E; Lutz J; Heemann U; Hösel V; Busch DH; Renders L; Neuenhahn M
PLoS One; 2017; 12(1):e0171035. PubMed ID: 28129395
[TBL] [Abstract][Full Text] [Related]
20. Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study.
Martín-Gandul C; Pérez-Romero P; Mena-Romo D; Molina-Ortega A; González-Roncero FM; Suñer M; Bernal G; Cordero E;
Transpl Infect Dis; 2018 Jun; 20(3):e12883. PubMed ID: 29570917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
